METOCLOPRAMIDE INTENSOL Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Metoclopramide Intensol, and when can generic versions of Metoclopramide Intensol launch?
Metoclopramide Intensol is a drug marketed by Roxane and is included in one NDA.
The generic ingredient in METOCLOPRAMIDE INTENSOL is metoclopramide hydrochloride. There are fourteen drug master file entries for this compound. Thirty-two suppliers are listed for this compound. Additional details are available on the metoclopramide hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Metoclopramide Intensol
A generic version of METOCLOPRAMIDE INTENSOL was approved as metoclopramide hydrochloride by TEVA on July 29th, 1985.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for METOCLOPRAMIDE INTENSOL?
- What are the global sales for METOCLOPRAMIDE INTENSOL?
- What is Average Wholesale Price for METOCLOPRAMIDE INTENSOL?
Summary for METOCLOPRAMIDE INTENSOL
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 89 |
| Patent Applications: | 105 |
| DailyMed Link: | METOCLOPRAMIDE INTENSOL at DailyMed |
US Patents and Regulatory Information for METOCLOPRAMIDE INTENSOL
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Roxane | METOCLOPRAMIDE INTENSOL | metoclopramide hydrochloride | CONCENTRATE;ORAL | 072995-001 | Jan 30, 1992 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
